En Chu Kong Hospital clinical trials
En Chu Kong Hospital is the lead sponsor of 3 current clinical trials in our Taiwan register. 3 are recruiting patients now. The most common phase is Not applicable. The most-studied condition is Ureteral Stenosis.
ClinicalTrials.gov trials by status
Trials by phase
Clinical trials sponsored by En Chu Kong Hospital
3 on ClinicalTrials.gov| Study | Phase | Status | Start | Registers |
|---|---|---|---|---|
|
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
NCT05455307 · ClinicalTrials.gov ↗ · Ureteral Stenosis, Hydronephrosis, Ureteral Stent Occlusion
|
Not applicable | Recruiting | 2022-07 | Taiwan |
|
Machine Learning for Evaluating and Diagnosing Temporomandibular Disorders
NCT07771296 · ClinicalTrials.gov ↗ · Temporomandibular Disorders (TMD), TMJ Disorder, TMJ Pain
|
Not applicable | Recruiting | 2026-10 | Taiwan |
|
Herbal Ointment in Treating Atopic Dermatitis Topically
NCT06850311 · ClinicalTrials.gov ↗ · Atopic Dermatitis, Atopic Dermatitis (AD), Atopic Dermatitis (Eczema)
|
Phase 2/3 | Recruiting | 2025-03 | Taiwan |
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Titles and statuses are copied from the registry as published.
Conditions in En Chu Kong Hospital trials
10 conditionsBy trial register
| Register | Trials | Recruiting |
|---|---|---|
| Clinical trials in Taiwan | 3 | 3 |
A trial with sites in more than one country appears in each of those registers.
Questions about En Chu Kong Hospital trials
How many clinical trials does En Chu Kong Hospital sponsor?
En Chu Kong Hospital is the lead sponsor of 3 current trials on ClinicalTrials.gov in our Taiwan register, as of the registry sync on 16 October 2026. Completed and withdrawn studies are not counted.
Are En Chu Kong Hospital trials recruiting?
Yes. 3 of its 3 ClinicalTrials.gov trials are recruiting. Eligibility and site contacts are on each trial's record. Only the study team can confirm whether a patient is eligible.
Where does this information come from?
Every trial, status, phase and condition on this page is copied from public ClinicalTrials.gov and EU CTIS records by a daily sync, grouped by the sponsor name each registry records. It says nothing about the organisation beyond its registered trials, and it is not medical advice.
How this page is built
Everything on this page is copied from public registry records — it is not written from memory, and nothing here describes the organisation beyond its registered trials. Each trial links to its own record so you can check it yourself.
- ClinicalTrials.gov (U.S. National Library of Medicine) ↗ Trial IDs, titles, lead sponsor, phase, overall status, start date, conditions and intervention names
- EU Clinical Trials Information System (CTIS) ↗ EU trial numbers, titles, sponsor, phase, status, therapeutic area and member-state countries
This page is built automatically: a daily sync job reads the registry records behind our trial registers and groups every current trial by its lead sponsor name, ignoring legal-form suffixes such as Inc. or Ltd. A small, hand-checked list joins the same organisation's different registry names (for example its EU legal entity). There is no AI drafting and no per-sponsor editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The the registries data on this page was last retrieved on 16 Oct 2026. How every register is built: methodology · fixes we have made: corrections log.